Finally, the altered function of adipose tissue in NAFLD contributes significantly to RAS activation, which results in an increased Ang-II secretion, promoting renal oxidative damage [103, 104]. The gene discussed is AGT; the disease is metabolic dysfunction-associated steatotic liver disease.